Clementia
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Clementia and buy or sell other stocks, options, and ETFs commission-free!About CMTA
Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. The company develops disease-modifying treatments for patients suffering from debilitating bone and other diseases with a high unmet medical need.
CEOClarissa Desjardins, PhD
CEOClarissa Desjardins, PhD
Employees—
Employees—
HeadquartersMontréal, Québec
HeadquartersMontréal, Québec
Founded2010
Founded2010
Employees—
Employees—
CMTA Key Statistics
Market cap997.72M
Market cap997.72M
Price-Earnings ratio-14.92
Price-Earnings ratio-14.92
Dividend yield—
Dividend yield—
Average volume267.67K
Average volume267.67K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$26.73
52 Week high$26.73
52 Week low$8.10
52 Week low$8.10